Qualigen Therapeutics, Inc. Annual Depreciation in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Qualigen Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2014 to 2022.
  • Qualigen Therapeutics, Inc. Depreciation for the quarter ending June 30, 2023 was $19K, a 20.8% decline year-over-year.
  • Qualigen Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2023 was $84K, a 4.55% decline year-over-year.
  • Qualigen Therapeutics, Inc. annual Depreciation for 2022 was $92K, a 26% increase from 2021.
  • Qualigen Therapeutics, Inc. annual Depreciation for 2021 was $73K.
  • Qualigen Therapeutics, Inc. annual Depreciation for 2019 was $6.1K, a 7.02% increase from 2018.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $92K +$19K +26% Jan 1, 2022 Dec 31, 2022 10-K 2023-05-02
2021 $73K Jan 1, 2021 Dec 31, 2021 10-K 2023-05-02
2019 $6.1K +$400 +7.02% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-31
2018 $5.7K -$20 -0.35% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-31
2017 $5.72K +$511 +9.81% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $5.21K +$3.27K +169% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-19
2015 $1.94K -$1.54K -44.3% Jan 1, 2015 Dec 31, 2015 10-K 2017-02-27
2014 $3.48K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.